Pozen: FDA disagrees with aspirin-pill finding – Marketwatch

Pharmaceutical company Pozen Inc. (NASDAQ:POZN) said the U.S. Food and Drug Administration disagreed with the company’s preliminary review in assessing the bioequivalence of its delayed-release aspirin tablet, PA32540, to enteric-coated aspirin …

Leave a Reply

Your email address will not be published. Required fields are marked *